Metabolic
Cagrilintide
Clinical trials
4.20 reviewsPrimary purposes
Fat loss, Appetite regulation
Relevant conditions
Obesity
Mechanism of action
Long-acting amylin analog that increases satiety; combined with semaglutide in CagriSema.
Details
Cagrilintide combined with semaglutide (CagriSema) showed around 20% weight loss in phase 3 trials.
Verified sources & manufacturers
Coming soon – we are building a list of verified studies and manufacturers. Learn more
Community experiences
Sign in to write reviews and share experiences.
No reviews yet – be the first.